News and Trends 16 Dec 2016 Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis Amcure and TILT Biotherapeutics announced yesterday new financing rounds supporting the development of unique strategies to cure cancer metastasis. Amcure, in Germany, is fighting highly metastatic forms of cancer by targeting angiogenesis. The company just closed a Series B round with a total of €6M from already existing investors. With the funds, Amcure plans to accelerate […] December 16, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials Kiadis Pharma has received approval to test in the UK an immune therapy to address the big challenges of bone marrow transplants, currently the only cure for blood cancers. Kiadis Pharma, based in Amsterdam, is working on therapies to improve the outcome of hematopoietic stem cell transplantation (HSCT), a common treatment for multiple types of […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 This Biofuel Company partnered with Audi is about to shake the Oil Market At Labiotech Refresh we had the opportunity to chat with Marc Delcourt, founder and CEO of Global Bioenergies, a biofuel pioneer challenging the oil market. Global Bioenergies, from France, uses synthetic biology to produce isobutene, the “building block of the chemical industry“. This molecule, currently extracted from oil, is essential for the manufacturing of gasoline, rubber, […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 UPDATE: European Stem Cell Therapy Pioneer goes for €34M IPO TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this move allow the company to make it through clinical trials? TiGenix is a Belgian company behind ChondroCellect, the first cell therapy approved on the European market. The biotech has now announced a Nasdaq IPO that aims to raise €39.8M in order to fund […] December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016 10 Awesome Biotech Gifts for you and your Geekiest Loved Ones Stuck on what to get your family and friends for Christmas? What about portable lab equipment or a stuffed version of your favorite microorganism? Biotech is one of the fastest growing sectors worldwide and a big employer in Europe. Providing solutions to cure, feed and fuel the world, who wouldn’t want to brag about this amazing field? Whether […] December 15, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 Deloitte’s Message to Pharma: Learn from Biotech or Perish The consulting firm’s annual financial report suggests pharma’s current model is not sustainable. The solution? Be more like biotech. Pharma has had a rollercoaster of a year, from anxiety about the US election to stellar CAR-T results after patient deaths. Overall, however, the numbers have not been great, and a new report from the analysts at […] December 14, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 Liquid Biopsies: Lowering the Defenses of Resistant Lung Cancer In response to new treatments, cancer came back stronger and more resistant than ever. Medicine’s counterattack will be more effective with a clear target. How do you solve a problem like drug resistance in cancer research? There’s no clear-cut answer yet, not least because the disease can vary so widely. But there has been some […] December 14, 2016 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 Swedish Therapy targeting All Solid Tumors enrolls First Patient Immunicum just received FDA approval to start clinical trials in the US for a therapy that could overcome the challenges of T-cell therapies and target virtually any injectable solid tumor. Immunicum is a biotech from Gothenburg, Sweden, that focuses on immuno-oncology with a different approach from most companies. Instead of T-cells, the company engineers dendritic […] December 14, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 UPDATE: Bayer seals deal with Monsanto in Dark Side slide Bloomberg reports that Bayer has increased its bid once more to acquire the world’s least ethical company in order to solidify its position in agrochemicals. Bayer appears hell-bent on a Faustian bargain with Monsanto: the German chemical company has just thrown more money at America’s fourth most hated company in the hope of acquiring it. Despite its […] December 14, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 What do the CAR-T Patient Deaths Mean for the Future of the Field? Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite the bad news, hopes for CAR-T therapies remain high. Juno Therapeutics again came under scrutiny last month following deaths in its JCAR015 trial. Two patients died from neurotoxicity-triggered cerebral edema, the same condition that killed […] December 14, 2016 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
Interview 13 Dec 2016 Meet the French Seaweed Startup rethinking Bioplastics Algopack is a French startup manufacturing bio-based materials made from brown algae. It is the first to use it to develop a new generation of bioplastics. Founded by Rémy Lucas in 2010 and managed by David Coti, Algopack offers a breakthrough innovation using marine natural resources as a unique renewable biomass. The company hopes to […] December 13, 2016 - 3 minutesmins - By Nicolas Sainte-Foie Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2016 How Will Biotech Overcome the Huge Challenges of Microbial Resistance? The emergence of multi-drug resistant pathogens is alarming the scientific community since their growth is increasing at an incredibly fast pace. We gathered a group of experts to discuss how biotech is addressing this pressing concern and what the next big thing will be in the field of antimicrobial resistance. Achim Plum, CCO of Curetis, highlighted that […] December 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email